Pink in the City marks 20 years fighting breast cancer in Quebec alongside the MUHC Foundation - CityNews Montreal

In the early days of the COVID-19 pandemic, many households wiped down groceries with disinfectant before putting them away. Hand sanitizer was in short supply. With little information on how the virus spread, people became more cautious of germs from other people. A new University of California San Diego study suggests that humans may not be alone in changing behavior after experiencing a disease threat.

Living with attention deficit hyperactivity disorder can exact a heavy toll on people’s health and longevity. Research out this week, however, shows that timely ADHD treatment may claw back some of those years. Scientists at the University of Liverpool in the UK and others examined the medical literature on ADHD. They found that having ADHD was associated with higher mortality rates, but that people taking ADHD medication were less likely to die early than those who went untreated. Though more research is warranted to quantify the benefits of medications and other treatments for ADHD, this study is the latest to illustrate the long-term health impacts of the condition, the researchers say. “These results reinforce the importance of targeted intervention and access to diagnosis and treatment for ADHD individuals across the lifespan,” the authors wrote in their paper, published Monday in JAMA Network Open. The toll of ADHD ADHD is a complex condition characterized by symptoms like restlessness, impulsiveness, and having trouble staying focused, especially on everyday tasks.

AHF ) and the Global Network of People Living with HIV ( GNP+ ) will convene a global webinar on Oct. 22 titled “